These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 19429088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis.
    Siegelin MD, Siegelin Y, Habel A, Gaiser T.
    Neurosci Lett; 2009 Apr 03; 453(2):92-7. PubMed ID: 19356600
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 8. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP.
    Cancer Res; 2005 Mar 15; 65(6):2344-52. PubMed ID: 15781649
    [Abstract] [Full Text] [Related]

  • 9. Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
    Kim EH, Kim SU, Choi KS.
    Oncogene; 2005 Jan 27; 24(5):838-49. PubMed ID: 15531913
    [Abstract] [Full Text] [Related]

  • 10. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ.
    Gene Ther; 2004 Apr 27; 11(8):658-67. PubMed ID: 14973547
    [Abstract] [Full Text] [Related]

  • 11. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death.
    Martín V, García-Santos G, Rodriguez-Blanco J, Casado-Zapico S, Sanchez-Sanchez A, Antolín I, Medina M, Rodriguez C.
    Cancer Lett; 2010 Jan 28; 287(2):216-23. PubMed ID: 19632770
    [Abstract] [Full Text] [Related]

  • 12. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
    Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS.
    Oncogene; 2005 Oct 20; 24(46):6877-89. PubMed ID: 16007142
    [Abstract] [Full Text] [Related]

  • 13. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma.
    Siegelin MD, Habel A, Gaiser T.
    Neurosci Lett; 2008 Dec 19; 448(1):161-5. PubMed ID: 18948169
    [Abstract] [Full Text] [Related]

  • 14. TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin.
    Gaiser T, Becker MR, Habel A, Reuss DE, Ehemann V, Rami A, Siegelin MD.
    Neurosci Lett; 2008 Sep 12; 442(2):109-13. PubMed ID: 18634847
    [Abstract] [Full Text] [Related]

  • 15. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Sep 12; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 16. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.
    Siegelin MD, Siegelin Y, Habel A, Rami A, Gaiser T.
    Neurobiol Dis; 2009 May 12; 34(2):259-66. PubMed ID: 19385057
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.
    Schultze K, Böck B, Eckert A, Oevermann L, Ramacher D, Wiestler O, Roth W.
    Apoptosis; 2006 Sep 12; 11(9):1503-12. PubMed ID: 16820965
    [Abstract] [Full Text] [Related]

  • 18. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
    Szliszka E, Krol W.
    Oncol Rep; 2011 Sep 12; 26(3):533-41. PubMed ID: 21637922
    [Abstract] [Full Text] [Related]

  • 19. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
    Lee JT, Lee TJ, Park JW, Kwon TK.
    Int J Oncol; 2009 May 12; 34(5):1455-60. PubMed ID: 19360359
    [Abstract] [Full Text] [Related]

  • 20. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.